Tag: immunotherapy
Combination Immunotherapy Shows Promise in Bladder Cancer Surgery: New NEJM Evidence
Combination enfortumab vedotin and pembrolizumab administered perioperatively shows emerging promise in muscle-invasive bladder cancer, according to new clinical correspondence in…
CAR T Cells Show Promise Against Smoldering Myeloma, But Patient Selection Is Critical
CAR T cell therapy achieves deep remissions in smoldering myeloma, a precancerous blood disorder, but induces severe toxicities in approximately…
CAR-T Cell Therapy Achieves Drug-Free Lupus Remission in German Trial
German trial shows CAR-T cell therapy achieved complete drug-free remission in all 15 severe lupus patients. The treatment reprograms the…
FDA Approves Sanofi’s Teplizumab for Children with Stage 3 Type 1 Diabetes
FDA approves Sanofi's teplizumab for children with stage 3 type 1 diabetes, expanding immunotherapy options for pediatric patients after previous…
Cancer’s Stealth Strategy Backfires, Creating New Therapeutic Target
Groundbreaking research reveals that cancer cells' common strategy to evade immune detection actually makes them more vulnerable to a different…
BioNTech-Pfizer Bispecific Antibody Shows Promise in Advanced Lung Cancer at ASCO 2026
BioNTech and Pfizer's experimental bispecific antibody BNT327 showed promising activity in advanced lung cancer patients at ASCO 2026. The dual-pathway…
CAR-T Cell Therapy Shows Promise for ‘Resetting’ Autoimmune Disease
CAR-T cell therapy shows remarkable promise for 'resetting' immune systems in autoimmune disease patients, with clinical trials demonstrating 68-85% remission…